Jazz to Acquire Actio Biosciences for Rare Epilepsy Drug
Dublin, Ireland & San Diego, California, USA, August 10, 2026 Jazz Pharmaceuticals plc and Actio Biosciences, Inc. have announced...
Epilepsy Treatment
Advertisement
NeuroPace Receives FDA Feedback on IGE PMA Supplement
MOUNTAIN VIEW, Calif., July 28, 2026 NeuroPace announced that the U.S. Food and Drug Administration (FDA) has informed the...
SK Life Science NDA for Cenobamate Suspension Accepted
PARAMUS, N.J., June 15, 2026 SK Life Science, Inc. has announced that the U.S. Food and Drug Administration (FDA)...
Jazz Reports Phase 3 Success for Ziihera in HER2+ GEA
DUBLIN, Ireland, May 27, 2026 Jazz Pharmaceuticals has announced the publication of pivotal Phase 3 HERIZON-GEA-01 trial results in...
Innocan Pharma Reports Strong Q1 Growth and Pipeline Progress
HERZLIYA, Israel and CALGARY, Alberta, May 27, 2026 Innocan Pharma Corporation has reported strong first-quarter 2026 financial results, highlighting...
Advertisements
ANI Pharma Launches Carbamazepine ER Capsules in US
PRINCETON, N.J., April 13, 2026 ANI Pharmaceuticals, Inc. has announced the commercial launch of Carbamazepine Extended-Release Capsules (100 mg,...
Jazz Pharmaceuticals Presents Neurology Drug Data at AAN
DUBLIN, Ireland, April 9, 2026 Jazz Pharmaceuticals plc has announced the presentation of six scientific abstracts, including one oral...
Rapport, Tenacia Partner to Develop RAP-219 in China
Boston, USA & Shanghai, China – March 9, 2026 Rapport Therapeutics and Tenacia Biotechnology have announced a strategic collaboration...
FDA Supports Consegna CP217 for Opioid Overdose Care
February 24, 2026 – Pittsburgh, Pennsylvania, USA Consegna Pharma, Inc. has announced that the U.S. Food and Drug Administration...
Lupin Launches Brivaracetam Oral Solution in US
February 24, 2026 – Mumbai, India & Naples, Florida, USA Global pharmaceutical leader Lupin Limited has announced that it...
Advertisement
